Stockscreener 앱 받기
0.42
0.62%
0.000100
Intensity Therapeutics Inc 주식(INTS)의 최신 뉴스
Why Intensity Therapeutics Inc. stock appeals to analystsEarnings Overview Report & Growth Focused Stock Reports - Улправда
Is Intensity Therapeutics Inc. stock supported by innovation pipelineDip Buying & Daily Volume Surge Trade Alerts - Улправда
Why Intensity Therapeutics Inc. stock is a must watch in 2025Earnings Growth Report & AI Forecasted Stock Moves - Улправда
Market Review: Why Intensity Therapeutics Inc. stock is a must watch in 2025IPO Watch & Verified Technical Signals - Улправда
MSN Money - MSN
Intensity Therapeutics to present two posters ay SABCS - MSN
Immuron (IMRN) struggles after announcing trial results - MSN
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - Yahoo Finance
Value Recap: Is Intensity Therapeutics Inc stock positioned for digital transformationJuly 2025 Snapshot & Technical Confirmation Trade Alerts - moha.gov.vn
Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium - PR Newswire
What drives Intensity Therapeutics Inc stock priceTechnology Stock Trends & Explosive Profit Potential - earlytimes.in
Intensity Therapeutics reports Q3 EPS (6c) vs. (25c) last year - MSN
You might want to take a look at Intensity Therapeutics Inc (INTS) now - setenews.com
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - marketscreener.com
HC Wainwright & Co. initiates coverage of Pasithea Therapeutics (KTTA) with buy recommendation - MSN
Intensity Therapeutics granted 180-day extension to regain Nasdaq compliance - MSN
INTS Stock Price and Chart — NASDAQ:INTS - TradingView
Update Report: How Intensity Therapeutics Inc stock benefits from global expansionPortfolio Gains Summary & AI Based Trade Execution Alerts - moha.gov.vn
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule - Investing.com Nigeria
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance - MSN
Intensity Therapeutics stock rises after securing Nasdaq listing extension By Investing.com - Investing.com Nigeria
Intensity Therapeutics stock rises after securing Nasdaq listing extension - Investing.com
Intensity Therapeutics Gets Extension to Regain Nasdaq Minimum Price Requirement - marketscreener.com
Intensity Therapeutics Granted Nasdaq Compliance Extension - TipRanks
Intensity Therapeutics granted 180-day extension - marketscreener.com
Intensity Therapeutics gets 180-day extension to meet Nasdaq price rule By Investing.com - Investing.com South Africa
Intensity Therapeutics jumps after Nasdaq grants compliance extension - TradingView — Track All Markets
Intensity Therapeutics, Inc. (INTS) 18.98% in Intraday Trading: Surge Ahead of Conference Presentations - Stocks Telegraph
Intensity Therapeutics expands at-the-market offering - MSN
Intensity Therapeutics files for offering of up to $30 million common stockSEC filing - marketscreener.com
Intensity Therapeutics expands at-the-market offering program to $30 million - Investing.com Australia
Intensity Therapeutics announces two presentations at the upcoming 2025 San Antonio Breast Cancer Symposium - marketscreener.com
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium - Nasdaq
Intensity Therapeutics expands at-the-market offering program to $30 million By Investing.com - Investing.com South Africa
Intensity Therapeutics Expands At-The-Market Offering - TipRanks
Intensity Therapeutics Expands ATM Offering to $30 Million - TradingView — Track All Markets
Chipmakers Recap: Why FARO Technologies Inc. stock could see breakout soonWall Street Watch & Momentum Based Trading Signals - BỘ NỘI VỤ
How Intensity Therapeutics Inc. stock benefits from global expansionEarnings Recap Report & Verified Chart Pattern Signals - Newser
Delving into the physics of cancer, with Lew Bender - pharmaphorum
Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga
The time has not yet come to remove your chips from the table: Intensity Therapeutics Inc (INTS) - setenews.com
Intensity Therapeutics shares plunge 30% after $4 million discounted stock offering - MSN
What analysts say about Intensity Therapeutics Inc stockSwing Trading Watchlist & Free Turn Volatility To Profit - earlytimes.in
Can Intensity Therapeutics Inc. stock resist sector downturnsJuly 2025 Rallies & Weekly High Momentum Picks - moha.gov.vn
Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire) - Aktiellt
Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - Aktiellt
Trading Recap: Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - BỘ NỘI VỤ
Intensity Therapeutics Inc (INTS) looking to reclaim success with recent performance - setenews.com
How Intensity Therapeutics Inc. stock reacts to oil prices2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Will Intensity Therapeutics Inc. stock benefit from AI adoptionMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
How to integrate Intensity Therapeutics Inc. into portfolio analysis tools2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Is Intensity Therapeutics Inc. stock oversold or undervaluedJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Will a bounce in Intensity Therapeutics Inc. offer an exitQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
0.21%
0.15%
자본화:
|
볼륨(24시간):